The importance of the link between LOX-1 and statins in arterial disease is further highlighted in a cohort study of 751 patients with hypercholesterolaemia receiving statin therapy: OLR1 (LOX-1) polymorphisms are linked to circulating LDL levels and risk of CVD [119]. This evidence concerns the gene OLR1 and arterial disorder.